FINWIRES · TerminalLIVE
FINWIRES

GSK's Linerixibat Gets UK Nod for Itch Linked to Biliary Disease

By

GSK's (GSK) Linerixibat, to be marketed as Lynavoy, has been approved by the UK's Medicines and Healthcare products Regulatory Agency for the treatment of itching in adults with primary biliary cholangitis, the agency said Friday.

The oral therapy aims to reduce bile acid buildup linked to the rare liver disease, which can cause persistent itching, the agency said.

The approval was supported by phase 3 data showing Linerixibat significantly reduced itching and improved sleep disruption compared with placebo, it added.

Shares of GSK were down 1.2% in Friday trading.

Price: $52.01, Change: $-0.30, Percent Change: -0.57%

Related Articles

Wire

Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased

Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.

$SKT
Wire

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Wire

GoDaddy Q1 Earnings, Revenue Rise; Shares Gain After Hours

GoDaddy (GDDY) reported Q1 earnings late Thursday of $1.60 per diluted share, up from $1.51 a year earlier.Analysts polled by FactSet expected $1.52.Revenue in the three months ended March 31 rose to $1.27 billion from $1.19 billion a year earlier.Analysts surveyed by FactSet expected $1.26 billion.The company expects Q2 revenue of $1.29 billion to $1.31 billion. Analysts surveyed by FactSet expect $1.29 billion.GoDaddy reaffirmed 2026 revenue guidance of $5.2 billion to $5.28 billion. Analysts surveyed by FactSet expect $5.24 billion.In Q1, the company repurchased 3 million shares for $279.7 million.GoDaddy shares rose 4.2% in after-hours trading.

$GDDY